サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：臨床試験用品の世界市場：市場規模、市場シェア、動向分析、機会、予測：製品別、臨床段階別、治療用途別、最終用途別、地域別（2019年～2029年）
市場調査レポート
商品コード
1217686

臨床試験用品の世界市場：市場規模、市場シェア、動向分析、機会、予測：製品別、臨床段階別、治療用途別、最終用途別、地域別（2019年～2029年）

Clinical Trial Supplies Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product ; By Clinical Phase ; By Therapeutic Use ; By End Use ; By Region
出版日: | 発行: Blueweave Consulting | ページ情報: 英文 270 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
臨床試験用品の世界市場：市場規模、市場シェア、動向分析、機会、予測：製品別、臨床段階別、治療用途別、最終用途別、地域別（2019年～2029年）
出版日: 2023年02月11日
発行: Blueweave Consulting
ページ情報: 英文 270 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の臨床試験用品の市場規模は、2022年の20億米ドルから2029年には29億米ドルに達し、2023年から2029年までの予測期間（2022年～2028年）中に5.09%のCAGRで成長すると予測されています。さまざまな慢性疾患や伝染病の有病率の上昇、製薬会社、政府、研究機関による臨床試験への多額の投資は、市場の成長を促進しています。

当レポートでは、世界の臨床試験用品市場について調査しており、市場概要、市場分析、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の臨床試験用品市場の洞察

  • 業界バリューチェーン分析
    • DROC分析
    • 促進要因
      • 医薬品およびバイオ医薬品の研究開発費の増加
      • 慢性疾患および伝染病の負担の増大
    • 抑制要因
      • 薬剤有害反応
    • 機会
      • 新興国における新薬開発試験の出現
    • 課題
      • COVID-19のサプライチェーンへの影響
  • 技術の進歩/最近の開発
  • 規制の枠組み
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争の激しさ

第4章 世界の臨床試験用品市場概要

  • 市場規模と予測（2019年～2029年）
    • 金額別（100万米ドル）
  • 市場シェアと予測
    • 製品別
      • 製造業
      • サプライチェーンマネジメント
      • ロジスティクス
      • 保管・流通
      • その他
    • 臨床段階別
      • フェーズⅠ
      • フェーズⅡ
      • フェーズⅢ
      • その他
    • 治療用途別
      • 腫瘍
      • 中枢神経系
      • 心臓血管
      • 感染症
      • 代謝障害
      • その他
    • 最終用途別
      • 医薬品
      • 生物製剤
      • 医療機器
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • ラテンアメリカ
      • 中東およびアフリカ

第5章 北米の臨床試験用品市場

第6章 欧州の臨床試験用品市場

第7章 アジア太平洋の臨床試験用品市場

第8章 ラテンアメリカの臨床試験用品市場

第9章 中東およびアフリカの臨床試験用品市場

第10章 競合情勢

  • 主要企業とその製品のリスト
  • 世界な臨床試験用品企業の市場シェア分析（2022年）
  • 競合ベンチマーキング：操作パラメータ別
  • 主要な戦略的展開（合併、買収、パートナーシップなど）

第11章 世界の臨床試験用品市場に対するCOVID-19の影響

第12章 企業プロファイル（企業概要、財務マトリックス、競合情勢、主要な人材、主要な競合、連絡先、戦略的展望、SWOT分析）

  • Alamc Group
  • Catalent, Inc.
  • PCI Services
  • Parexel International Corporation
  • Sharp Packaging Services
  • Biocair
  • O&M Movianto
  • KLIFO A/S
  • Thermo Fisher Scientific, Inc.
  • Movianto
  • Sharp
  • Catalent, Inc
  • Bionical Ltd.
  • Alium Medical Limited
  • その他

第13章 主要な戦略的推奨事項

第14章 調査手法

目次
Product Code: BWC20102

Global Clinical Trial Supplies Market Size Booming to Touch USD 3 Billion by 2029

Global clinical trial supplies market is gaining traction because of an increasing focus on R&D innovative medicines to treat growing prevalence of various chronic and communicable illnesses as well as significant investments in clinical trials by pharmaceutical firms, governments, and research institutions.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global clinical trial supplies market size at USD 2 billion in 2022. During the forecast period between 2023 and 2029, the global clinical trial supplies market size is projected to grow at a steady CAGR of 5.09% reaching a value of USD 2.9 billion by 2029. The increased prevalence of different chronic and communicable illnesses as well as significant investments in clinical trials by pharmaceutical firms, governments, and research institutions are key growth drivers for the global clinical trial supplies market. The global clinical trial supplies market is expected to grow during the forecast period as a result of the pharmaceutical and biotechnology firms' increasing investments in research and development activities for medication development.

Global Clinical Trial Supplies Market - Overview:

Clinical trials are research projects conducted on human subjects to assess a therapeutic, surgical, or behavioral intervention. Clinical trials often fall into one of three categories: Interventional studies seek to learn more about a specific intervention or kind of treatment. Observational studies seek to understand how individuals behave in various contexts. Feasibility studies are intended to determine whether the primary research can be conducted. The provision of materials needed to execute a clinical trial is known as clinical supply or clinical trial supply. This includes the 24-hour collection and distribution of biological specimens (including infectious samples), experimental medications, kits, and other research materials and supplies, as well as knowledge and help.

Global Clinical Trial Supplies Market - By End Use:

Based on end use, the global clinical trial supplies market is segmented into pharmaceuticals, biologics, medical devices, and others. Pharmaceutical companies account for the highest market share owing to the increasing number of clinical trials for drug development. Pharmaceutical companies use clinical trial supplies for collection and delivery of biological specimens, investigational drugs, and others. However, the biologics segment is expected to gain high traction during the forecast period owing to extensive research activities around the development of drugs from biologics such as blood, proteins, viruses, or living organisms.

Impact of COVID-19 on the Global Clinical Trial Supplies Market

COVID-19 elevated the critical nature of clinical trial supplies and their importance to the healthcare market. Although the global clinical trial supplies market was initially hindered during the pandemic period as the imposition of lockdowns in various countries halted the clinical trials of various therapeutic purposes, which significantly impacted the market growth. To complete vaccine development activities after the pandemic outbreak and stop any further human deaths, clinical trial sponsors, their clinical research organizations, study teams, and other important stakeholders, such as vendors, had to work cooperatively to secure clinical trial supplies.

Competitive Landscape:

Major players operating in the global Clinical Trial Supplies market include Almac Group, Catalent, Inc., PCI Services, Parexel International Corporation, Sharp Packaging Services, Biocair, O&M Movianto, KLIFO A/S, Thermo Fisher Scientific, Inc., Movianto, Sharp, Catalent, Inc, Bionical Ltd., and Alium Medical Limited. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Clinical Trial Supplies Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Clinical Trial Supplies Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Clinical Trial Supplies Market Insights

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. DROC Analysis
    • 3.1.2. Growth Drivers
      • 3.1.2.1. Increasing Pharmaceutical and Biopharmaceutical R&D Expenditures
      • 3.1.2.2. Rising Burden of Chronic and Communicable Diseases
    • 3.1.3. Restraints
      • 3.1.3.1. Adverse Drug Reactions
    • 3.1.4. Opportunities
      • 3.1.4.1. Rising New Drug Development Trial in Emerging Countries
    • 3.1.5. Challenges
      • 3.1.5.1. Impact of COVID-19 on Supply Chain
  • 3.2. Technology Advancements/Recent Developments
  • 3.3. Regulatory Framework
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of New Entrants
    • 3.4.4. Threat of Substitutes
    • 3.4.5. Intensity of Rivalry

4. Global Clinical Trial Supplies Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Manufacturing
      • 4.2.1.2. Supply Chain Management
      • 4.2.1.3. Logistics
      • 4.2.1.4. Storage & Distribution
      • 4.2.1.5. Others
    • 4.2.2. By Clinical Phase
      • 4.2.2.1. Phase I
      • 4.2.2.2. Phase II
      • 4.2.2.3. Phase III
      • 4.2.2.4. Others
    • 4.2.3. By Therapeutic use
      • 4.2.3.1. Oncology
      • 4.2.3.2. CNS
      • 4.2.3.3. Cardiovascular
      • 4.2.3.4. Infectious Disease
      • 4.2.3.5. Metabolic Disorders
      • 4.2.3.6. Others
    • 4.2.4. By End Use
      • 4.2.4.1. Pharmaceutical
      • 4.2.4.2. Biologics
      • 4.2.4.3. Medical Device
      • 4.2.4.4. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia Pacific (APAC)
      • 4.2.5.4. Latin America
      • 4.2.5.5. Middle East and Africa (MEA)

5. North America Clinical Trial Supplies Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Clinical Phase
    • 5.2.3. By Therapeutic use
    • 5.2.4. By End Use
    • 5.2.5. By Country
      • 5.2.5.1. US
      • 5.2.5.1.1. By Product
      • 5.2.5.1.2. By Clinical Phase
      • 5.2.5.1.3. By Therapeutic use
      • 5.2.5.1.4. By End Use
      • 5.2.5.2. Canada
      • 5.2.5.2.1. By Product
      • 5.2.5.2.2. By Clinical Phase
      • 5.2.5.2.3. By Therapeutic use
      • 5.2.5.2.4. By End Use

6. Europe Clinical Trial Supplies Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Clinical Phase
    • 6.2.3. By Therapeutic use
    • 6.2.4. By End Use
    • 6.2.5. By Country
      • 6.2.5.1. Germany
      • 6.2.5.1.1. By Product
      • 6.2.5.1.2. By Clinical Phase
      • 6.2.5.1.3. By Therapeutic use
      • 6.2.5.1.4. By End Use
      • 6.2.5.2. UK
      • 6.2.5.2.1. By Product
      • 6.2.5.2.2. By Clinical Phase
      • 6.2.5.2.3. By Therapeutic use
      • 6.2.5.2.4. By End Use
      • 6.2.5.3. Italy
      • 6.2.5.3.1. By Product
      • 6.2.5.3.2. By Clinical Phase
      • 6.2.5.3.3. By Therapeutic use
      • 6.2.5.3.4. By End Use
      • 6.2.5.4. France
      • 6.2.5.4.1. By Product
      • 6.2.5.4.2. By Clinical Phase
      • 6.2.5.4.3. By Therapeutic use
      • 6.2.5.4.4. By End Use
      • 6.2.5.5. Spain
      • 6.2.5.5.1. By Product
      • 6.2.5.5.2. By Clinical Phase
      • 6.2.5.5.3. By Therapeutic use
      • 6.2.5.5.4. By End Use
      • 6.2.5.6. The Netherlands
      • 6.2.5.6.1. By Product
      • 6.2.5.6.2. By Clinical Phase
      • 6.2.5.6.3. By Therapeutic use
      • 6.2.5.6.4. By End Use
      • 6.2.5.7. Rest of Europe
      • 6.2.5.7.1. By Product
      • 6.2.5.7.2. By Clinical Phase
      • 6.2.5.7.3. By Therapeutic use
      • 6.2.5.7.4. By End Use

7. Asia-Pacific Clinical Trial Supplies Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Clinical Phase
    • 7.2.3. By Therapeutic use
    • 7.2.4. By End Use
    • 7.2.5. By Country
      • 7.2.5.1. China
      • 7.2.5.1.1. By Product
      • 7.2.5.1.2. By Clinical Phase
      • 7.2.5.1.3. By Therapeutic use
      • 7.2.5.1.4. By End Use
      • 7.2.5.2. India
      • 7.2.5.2.1. By Product
      • 7.2.5.2.2. By Clinical Phase
      • 7.2.5.2.3. By Therapeutic use
      • 7.2.5.2.4. By End Use
      • 7.2.5.3. Japan
      • 7.2.5.3.1. By Product
      • 7.2.5.3.2. By Clinical Phase
      • 7.2.5.3.3. By Therapeutic use
      • 7.2.5.3.4. By End Use
      • 7.2.5.4. South Korea
      • 7.2.5.4.1. By Product
      • 7.2.5.4.2. By Clinical Phase
      • 7.2.5.4.3. By Therapeutic use
      • 7.2.5.4.4. By End Use
      • 7.2.5.5. Australia & New Zealand
      • 7.2.5.5.1. By Product
      • 7.2.5.5.2. By Clinical Phase
      • 7.2.5.5.3. By Therapeutic use
      • 7.2.5.5.4. By End Use
      • 7.2.5.6. Indonesia
      • 7.2.5.6.1. By Product
      • 7.2.5.6.2. By Clinical Phase
      • 7.2.5.6.3. By Therapeutic use
      • 7.2.5.6.4. By End Use
      • 7.2.5.7. Malaysia
      • 7.2.5.7.1. By Product
      • 7.2.5.7.2. By Clinical Phase
      • 7.2.5.7.3. By Therapeutic use
      • 7.2.5.7.4. By End Use
      • 7.2.5.8. Singapore
      • 7.2.5.8.1. By Product
      • 7.2.5.8.2. By Clinical Phase
      • 7.2.5.8.3. By Therapeutic use
      • 7.2.5.8.4. By End Use
      • 7.2.5.9. Philippines
      • 7.2.5.9.1. By Product
      • 7.2.5.9.2. By Clinical Phase
      • 7.2.5.9.3. By Therapeutic use
      • 7.2.5.9.4. By End Use
      • 7.2.5.10. Vietnam
      • 7.2.5.10.1. By Product
      • 7.2.5.10.2. By Clinical Phase
      • 7.2.5.10.3. By Therapeutic use
      • 7.2.5.10.4. By End Use
      • 7.2.5.11. Rest of APAC
      • 7.2.5.11.1. By Product
      • 7.2.5.11.2. By Clinical Phase
      • 7.2.5.11.3. By Therapeutic use
      • 7.2.5.11.4. By End Use

8. Latin America Clinical Trial Supplies Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Clinical Phase
    • 8.2.3. By Therapeutic use
    • 8.2.4. By End Use
    • 8.2.5. By Country
      • 8.2.5.1. Brazil
      • 8.2.5.1.1. By Product
      • 8.2.5.1.2. By Clinical Phase
      • 8.2.5.1.3. By Therapeutic use
      • 8.2.5.1.4. By End Use
      • 8.2.5.2. Mexico
      • 8.2.5.2.1. By Product
      • 8.2.5.2.2. By Clinical Phase
      • 8.2.5.2.3. By Therapeutic use
      • 8.2.5.2.4. By End Use
      • 8.2.5.3. Argentina
      • 8.2.5.3.1. By Product
      • 8.2.5.3.2. By Clinical Phase
      • 8.2.5.3.3. By Therapeutic use
      • 8.2.5.3.4. By End Use
      • 8.2.5.4. Peru
      • 8.2.5.4.1. By Product
      • 8.2.5.4.2. By Clinical Phase
      • 8.2.5.4.3. By Therapeutic use
      • 8.2.5.4.4. By End Use
      • 8.2.5.5. Rest of LATAM
      • 8.2.5.5.1. By Product
      • 8.2.5.5.2. By Clinical Phase
      • 8.2.5.5.3. By Therapeutic use
      • 8.2.5.5.4. By End Use

9. Middle East & Africa Clinical Trial Supplies Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Clinical Phase
    • 9.2.3. By Therapeutic use
    • 9.2.4. By End Use
    • 9.2.5. By Country
      • 9.2.5.1. Saudi Arabia
      • 9.2.5.1.1. By Product
      • 9.2.5.1.2. By Clinical Phase
      • 9.2.5.1.3. By Therapeutic use
      • 9.2.5.1.4. By End Use
      • 9.2.5.2. UAE
      • 9.2.5.2.1. By Product
      • 9.2.5.2.2. By Clinical Phase
      • 9.2.5.2.3. By Therapeutic use
      • 9.2.5.2.4. By End Use
      • 9.2.5.3. Qatar
      • 9.2.5.3.1. By Product
      • 9.2.5.3.2. By Clinical Phase
      • 9.2.5.3.3. By Therapeutic use
      • 9.2.5.3.4. By End Use
      • 9.2.5.4. Kuwait
      • 9.2.5.4.1. By Product
      • 9.2.5.4.2. By Clinical Phase
      • 9.2.5.4.3. By Therapeutic use
      • 9.2.5.4.4. By End Use
      • 9.2.5.5. South Africa
      • 9.2.5.5.1. By Product
      • 9.2.5.5.2. By Clinical Phase
      • 9.2.5.5.3. By Therapeutic use
      • 9.2.5.5.4. By End Use
      • 9.2.5.6. Nigeria
      • 9.2.5.6.1. By Product
      • 9.2.5.6.2. By Clinical Phase
      • 9.2.5.6.3. By Therapeutic use
      • 9.2.5.6.4. By End Use
      • 9.2.5.7. Algeria
      • 9.2.5.7.1. By Product
      • 9.2.5.7.2. By Clinical Phase
      • 9.2.5.7.3. By Therapeutic use
      • 9.2.5.7.4. By End Use
      • 9.2.5.8. Rest of MEA
      • 9.2.5.8.1. By Product
      • 9.2.5.8.2. By Clinical Phase
      • 9.2.5.8.3. By Therapeutic use
      • 9.2.5.8.4. By End Use

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Clinical Trial Supplies Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Clinical Trial Supplies Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Alamc Group
  • 12.2. Catalent, Inc.
  • 12.3. PCI Services
  • 12.4. Parexel International Corporation
  • 12.5. Sharp Packaging Services
  • 12.6. Biocair
  • 12.7. O&M Movianto
  • 12.8. KLIFO A/S
  • 12.9. Thermo Fisher Scientific, Inc.
  • 12.10. Movianto
  • 12.11. Sharp
  • 12.12. Catalent, Inc
  • 12.13. Bionical Ltd.
  • 12.14. Alium Medical Limited
  • 12.15. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations